secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immuneering Corp (IMRX)
CIK:        0001790340
Form:       8-K/A
Filed at:   2022-09-19T23:59:59+00:00
Accession:  0001104659-22-101186
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Immuneering appoints Dr. Hausman to compensation committee and as chair of NCG committee
--------------------------------------------------------------------------------

- Dr. Hausman appointed to Compensation Committee and as member and Chair of Nominating and Corporate Governance Committee, effective Sept 15, 2022.
- She replaces Mr. Carpenter on the NCG Committee.
- Dr. Hausman had been elected to the Board as a Class I director on Jan 14, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922101186/0001104659-22-101186-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1790340/000110465922101186/tm2226080d1_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-101186

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer